Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
63.25
+1.25 (2.02%)
At close: Aug 13, 2025, 4:00 PM
60.67
-2.58 (-4.08%)
Pre-market: Aug 14, 2025, 9:05 AM EDT
Cidara Therapeutics Employees
Cidara Therapeutics had 38 employees as of December 31, 2024. The number of employees decreased by 31 or -44.93% compared to the previous year.
Employees
38
Change (1Y)
-31
Growth (1Y)
-44.93%
Revenue / Employee
n/a
Profits / Employee
-$3,091,842
Market Cap
1.60B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CDTX News
- 5 days ago - Cidara Therapeutics, Inc. (CDTX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 21 days ago - Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025 - GlobeNewsWire
- 5 weeks ago - Segal Trials Contributes to Breakthrough Flu Prevention Study Led by Cidara Therapeutics - Business Wire
- 6 weeks ago - Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 6 weeks ago - Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 6 weeks ago - Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 7 weeks ago - Cidara Therapeutics Advances CD388 To Phase 3, Reiterate Buy - Seeking Alpha